Aortic Aneurysm Market Size & Growth Forecast 2026–2035, By Segments (Type, Treatment, Product, End-use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growoth Outlook
Aortic Aneurysm Market size was around USD 6.11 Billion in 2025 and is slated to grow at a 10.5% CAGR from 2026 to 2035, crossing USD 16.58 Billion by 2035. The industry revenue for 2026 is estimated at USD 6.68 billion.
Get more details on this report
Request Free Sample ReportAortic Aneurysm Market Intelligence Snapshot
Regional Market Dynamics
- North America accounted for 48.76% of the market in 2025, supported by established vascular care pathways, advanced diagnostic imaging, strong hospital infrastructure, and high procedural adoption for aneurysm management.
- Asia Pacific is projected to grow at an 11.76% CAGR as expanding hospital capabilities, improved vascular diagnosis, minimally invasive procedures, and broader access to specialist care accelerate treatment adoption.
Segment Momentum
- Abdominal Aortic Aneurysm (AAA) held a 61.38% share in 2025 due to established screening pathways, consistent diagnosis, and well-defined treatment practices that support steady clinical management and intervention volumes.
- EVAR is the fastest-growing treatment and held a 57.47% share in 2025 because clinicians increasingly prefer minimally invasive procedures that improve treatment accessibility and fit modern vascular care pathways.
Market Expansion Drivers
- Increasing prevalence of aortic aneurysms driven by aging population and cardiovascular risk factors.
- Growth of minimally invasive EVAR and TEVAR procedures improving patient outcomes.
- Expansion of national screening programs enabling early aneurysm detection and treatment.
Leading Market Participants
Global Market Forecast Snapshot
Market Outlook
Prominent players in the aortic aneurysm market include Medtronic plc (Ireland), W. L. Gore & Associates, Inc. (United States), Cook Medical LLC (United States), Boston Scientific Corporation (United States), Endologix LLC (United States), MicroPort Scientific Corporation (China), Artivion, Inc. (United States), Lombard Medical Technologies GmbH (Germany), Braile Biomédica S.A. (Brazil), Cordis Corporation (United States).Regional and Segment Outlook
North AmericaMarket Growth Drivers and Industry Trends
Rising exposure to age-related vascular degeneration, hypertension, smoking history, and atherosclerotic disease is steadily enlarging the addressable patient pool for the aortic aneurysm market. As more patients present with incidental findings during cardiovascular imaging or enter surveillance after diagnosis, hospitals and vascular specialists are managing a larger volume of monitoring, risk stratification, and intervention decisions. This trends purchasing and treatment activity toward aneurysm repair devices, follow-up imaging, and specialist care pathways, reinforcing market demand through both newly diagnosed cases and the ongoing management needs of patients who are not treated immediately.
Growth of minimally invasive EVAR and TEVAR procedures improving patient outcomes
The wider adoption of endovascular aneurysm repair (EVAR) and thoracic endovascular aortic repair (TEVAR) is reshaping treatment patterns in the aortic aneurysm market by making intervention feasible for patients who may not be ideal candidates for open surgery. Shorter hospital stays, lower perioperative burden, and faster recovery are influencing physician preference and hospital protocol, which supports stronger use of stent graft systems, delivery catheters, and related imaging-guided procedural tools. As centers build endovascular capabilities and referral networks increasingly direct patients toward less invasive options, procedure volumes rise through practical gains in treatment accessibility and clinician confidence.
Expansion of national screening programs enabling early aneurysm detection and treatment
Broader implementation of organized screening is increasing the number of aneurysms identified before rupture or acute presentation, which changes how demand develops in the aortic aneurysm market. Earlier detection moves more patients into structured surveillance and elective treatment pathways, where clinicians can plan interventions under more controlled conditions and select devices based on anatomical suitability rather than emergency constraints. This improves the flow of diagnosed patients into vascular care services and supports market expansion by converting previously undetected disease into measurable demand for imaging, monitoring, and scheduled repair procedures.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Increasing prevalence of aortic aneurysms driven by aging population and cardiovascular risk factors | 2.40% | High | North America, Europe | High | Near Term |
| Growth of minimally invasive EVAR and TEVAR procedures improving patient outcomes | 2.10% | High | North America, Europe, Asia Pacific | High | Mid Term |
| Expansion of national screening programs enabling early aneurysm detection and treatment | 1.80% | High | Europe, North America | Medium | Long Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America held the leading regional share of the aortic aneurysm market in 2025, accounting for 48.76% share, backed by established vascular care pathways, broad access to advanced diagnostic imaging, and high procedural adoption across major treatment centers. The region’s leadership is reinforced by routine detection through well-developed screening and referral systems, which brings more patients into specialist care earlier and supports steady demand for both surveillance and intervention. Strong hospital infrastructure and familiarity with endovascular and surgical repair techniques also help sustain procedure volumes in everyday clinical practice.
Asia Pacific is projected to expand at an 11.76% CAGR over the forecast period, with growth in the aortic aneurysm market being fueled by improving access to vascular diagnosis and treatment across developing healthcare systems. Expansion of hospital capabilities, rising availability of minimally invasive procedures, and broader patient access to specialist services are accelerating adoption in practice. As more healthcare providers build capacity to identify and manage aneurysm cases, the region is seeing stronger procedural momentum and a wider treatment base across key markets.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Precision Vascular CareGermany prioritizes evidence-based vascular treatment pathways and specialized cardiovascular centers for aortic aneurysm management. Demand in Germany is supported by the adoption of advanced stent graft systems and continued focus on improving treatment efficiency for aging patient populations.
France 🇫🇷
Structured Screening FocusFrance emphasizes coordinated screening and referral pathways to identify aneurysm cases earlier and optimize treatment planning. French healthcare institutions continue to adopt less invasive repair techniques while strengthening multidisciplinary vascular care services.
Italy 🇮🇹
Specialized Surgical NetworksItaly's aortic aneurysm market relies on established vascular surgery centers that manage complex aneurysm cases and support device adoption. In Italy, clinicians are increasingly balancing conventional surgery with endovascular procedures to improve patient recovery and resource utilization.
Japan 🇯🇵
Aging Population ManagementJapan's aortic aneurysm market is influenced by a large elderly population requiring long-term monitoring and intervention. Healthcare providers in Japan increasingly favor minimally invasive repair approaches and routine imaging surveillance to reduce complications associated with aneurysm progression.
South Korea 🇰🇷
Technology-Enabled InterventionSouth Korea is integrating advanced imaging and catheter-based procedures into aortic aneurysm treatment strategies. The market in South Korea benefits from strong tertiary care infrastructure and growing use of sophisticated endovascular devices in major cardiovascular centers.
United States 🇺🇸
Advanced Endovascular AdoptionThe U.S. aortic aneurysm market is shaped by widespread use of endovascular repair technologies and increasing emphasis on surveillance programs for high-risk patients. Hospitals in the U.S. continue investing in minimally invasive devices and imaging-guided interventions to improve procedural outcomes.
Segment Leadership and Growth Trends
Aortic Aneurysm Market Share (%), Type, 2025
Go beyond the chart, access full insights & data tables
Request Free Sample ReportAbdominal Aortic Aneurysm (AAA) held the dominant position in the aortic aneurysm market in 2025, accounting for a 61.38% share. its position is underpinned by the higher procedural and diagnostic focus placed on abdominal aneurysms in routine vascular care, where established screening pathways and clearer intervention thresholds support steady case identification and treatment volumes. This keeps Abdominal Aortic Aneurysm (AAA) firmly dominant in the aortic aneurysm market, as it remains the segment most consistently addressed across standard clinical practice.
Thoracic Aortic Aneurysm (TAA) is the fastest-growing segment in the aortic aneurysm market as clinical attention increasingly shifts toward earlier detection and management of more complex aortic conditions. Growth is being backed by improving diagnostic reach and rising treatment readiness for thoracic cases, which historically faced greater procedural complexity than abdominal aneurysms. As care capabilities strengthen, Thoracic Aortic Aneurysm (TAA) is gaining momentum faster than alternatives because a larger share of previously under-addressed patients is now moving into active monitoring and intervention pathways.
Treatment Segment Analysis: Endovascular Aneurysm Repair (EVAR) (Largest & Fastest-Growing Segment)
In 2025, Endovascular Aneurysm Repair (EVAR) led the aortic aneurysm market with a 57.47% share, while also recording the fastest growth within the treatment segment. Its strong position reflects the market’s clear preference for less invasive aneurysm management approaches that fit more efficiently into current vascular treatment pathways and support broader procedural adoption. The continued expansion of Endovascular Aneurysm Repair (EVAR) in the aortic aneurysm market is being reinforced by its practical alignment with evolving clinical practice, where treatment decisions increasingly favor interventions that can improve procedural accessibility and patient throughput without relying on open surgical management.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Type | Thoracic Aortic Aneurysm (TAA), Abdominal Aortic Aneurysm (AAA) | Abdominal Aortic Aneurysm (AAA) | Thoracic Aortic Aneurysm (TAA) |
| Treatment | Open Surgical Repair (OSR), Endovascular Aneurysm Repair (EVAR) | Endovascular Aneurysm Repair (EVAR) | Endovascular Aneurysm Repair (EVAR) |
| Product | Stent Grafts, Catheters | Stent Grafts | Catheters |
| End-use | Hospitals, Ambulatory Surgery Centers, Clinics | Hospitals | Ambulatory Surgery Centers |
Competitive Landscape and Market Positioning
1. Medtronic plc (Ireland)
2. W. L. Gore & Associates Inc. (United States)
3. Cook Medical LLC (United States)
4. Boston Scientific Corporation (United States)
5. Endologix LLC (United States)
6. MicroPort Scientific Corporation (China)
7. Artivion Inc. (United States)
8. Lombard Medical Technologies GmbH (Germany)
9. Braile Biomédica S.A. (Brazil)
10. Cordis Corporation (United States)
In the aortic aneurysm market, innovation is focused on improving diagnostic precision and treatment effectiveness. Collaborative clinical research initiatives are supporting the development of advanced therapeutic approaches. New solution introductions are enhancing procedural outcomes, while continuous technological improvements are strengthening patient care standards in the aortic aneurysm market.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| No companies available. | |||||||
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Nectero | Apr-26 | Nectero, supported by Boston Scientific, reported positive mid-stage clinical results for its EAST System (PGG therapy), showing slowed abdominal aortic aneurysm growth in 90% of patients over two years. The ongoing Phase II/III trial is critical for validating the device’s disease-modifying potential in managing AAA, representing a significant shift toward pharmaceutical-like intervention in vascular surgery. |
| W. L. Gore & Associates | Jul-25 | W. L. Gore & Associates secured CE Mark approval for its lower-profile GORE VIABAHN VBX Balloon Expandable Endoprosthesis. Compatibility with 6 Fr sheaths enhances the device's utility as a bridging stent for complex FEVAR and BEVAR procedures, supporting improved procedural efficiency and technical flexibility in endovascular aneurysm repair. |
| Vivasure Medical | Jun-25 | Vivasure Medical received approval for its PerQseal Elite, a fully bioresorbable, sutureless vascular closure device. The system allows for streamlined large-bore closure in interventions including EVAR, potentially reducing complications and enhancing procedural safety during minimally invasive cardiovascular surgeries across European markets. |
| Endoron Medical | Jul-24 | Endoron Medical secured $10 million in Series A funding led by Sofinnova Partners to accelerate the clinical validation of its Aortoseal catheter-based endostapling system. The capital supports early feasibility studies and development aimed at improving fixation technology in endovascular abdominal aortic aneurysm repair, addressing critical durability requirements for complex aortic procedures. |
| Shape Memory Medical | Mar-24 | Shape Memory Medical closed a $38 million Series C financing round to scale its proprietary shape memory polymer-based embolic technology. The investment supports the commercial expansion of its endovascular embolisation portfolio, targeting improved clinical outcomes for vascular conditions, including complex aortic aneurysms, by leveraging advanced material science in minimally invasive repair. |
| Terumo Aortic | Jul-24 | Terumo Aortic successfully completed the first commercial implantation of its Fenestrated TREO device in Asia. This milestone marks a significant geographic expansion for the company’s advanced endovascular aneurysm repair (EVAR) portfolio, strengthening its competitive positioning in high-growth regional markets requiring sophisticated solutions for complex aortic anatomies. |
| Bentley | Nov-24 | Bentley announced the first-in-human implantation of its BeFlared bridging stent graft system. This clinical milestone validates the device's design, which aims to improve aortic aneurysm repair by offering enhanced graft support and deployment precision, directly addressing technical challenges associated with treating complex vascular anatomies. |
Explore This Report
Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.
Aortic Aneurysm Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| No segment data available. | |
Aortic Aneurysm Market — report.custom
| Custom Chapter | Custom Details | ||
|---|---|---|---|
| No custom TOC data available. | |||
Need a different cut of the data?
Request Custom ResearchHow much is the aortic aneurysm market worth?
How is the aortic aneurysm industry expected to grow over the next 10 years?
How are aging-related risk factors and expanding screening practices shaping demand in the aortic aneurysm market?
How is the shift toward minimally invasive EVAR and TEVAR procedures influencing treatment adoption patterns?
Why does Abdominal Aortic Aneurysm (AAA) dominate the aortic aneurysm market?
Why is Endovascular Aneurysm Repair (EVAR) the fastest-growing treatment in the aortic aneurysm market?
Why does North America lead the aortic aneurysm market?
Why is Asia Pacific the fastest-growing region in the aortic aneurysm market?
What are the key competitors in the aortic aneurysm landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source Category | Research Sources | Purpose |
|---|---|---|
| Government Publications | Government agencies, statistical departments, regulatory bodies | Industry statistics, regulatory insights, and policy analysis |
| Company Disclosures | Annual reports, investor presentations, financial filings | Company performance, business strategy, and market positioning |
| Trade Associations | Industry associations and professional organizations | Industry developments, standards, and market perspectives |
| Technical Literature | Research papers, technical publications, academic journals | Technology developments and technical validation |
| Patent Analysis | Patent databases and intellectual property publications | Innovation trends, technology activity, and competitive research |
| Industry Databases | Established research databases and market intelligence resources | Market benchmarking, historical data, and industry analysis |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization